Streetbeat News

Price Targets

RGLD

In the past three months, six analysts have provided ratings for Royal Gold (NASDAQ:RGLD), with a mix of somewhat bullish and indifferent sentiments. The average 12-month price target has increased by 5.11% to $161.17. Analysts have raised their price targets, reflecting a positive outlook on Royal Gold's financial performance, including strong revenue growth and profitability metrics.

Portfolio Pulse from Benzinga Insights

October 04, 2024 | 7:02 pm

SCHW

Analysts have mixed views on Charles Schwab (NYSE:SCHW) with recent ratings showing a blend of bullish and bearish sentiments. The average 12-month price target has decreased by 5.41% to $74.78. Analysts have adjusted their ratings and price targets in response to market dynamics, with several lowering their targets. Despite challenges in revenue growth and returns, Schwab maintains a strong market position with a large market cap and efficient cost management.

Portfolio Pulse from Benzinga Insights

October 04, 2024 | 7:01 pm

RJF

Raymond James Financial (NYSE:RJF) has been evaluated by 7 analysts over the past three months, with most ratings being indifferent. The average 12-month price target is $130.71, slightly up from $129.50. Analysts have adjusted their ratings and price targets based on market conditions and company performance. RJF has shown a revenue growth rate of 10.92% and a net margin of 15.41%, but its ROA is below industry averages.

Portfolio Pulse from Benzinga Insights

October 04, 2024 | 7:01 pm

GBTG

Citigroup analyst Peter Christiansen has maintained a Buy rating on Global Business Travel (NYSE:GBTG) and raised the price target from $9 to $9.5.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 7:00 pm

REGN

Over the past three months, 24 analysts have evaluated Regeneron Pharmaceuticals (NASDAQ:REGN), with a majority being somewhat bullish. The average 12-month price target has increased by 3.71% to $1194.29. Analysts have adjusted their ratings and price targets, reflecting their response to recent developments. Regeneron has shown strong financial performance with a notable net margin and ROE, despite lagging revenue growth compared to peers.

Portfolio Pulse from Benzinga Insights

October 04, 2024 | 7:00 pm

ONON

On Holding shares are experiencing an upward trend following multiple analyst price target increases. This positive sentiment from analysts is likely driving the stock's current performance.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 6:58 pm

ST

JP Morgan analyst Samik Chatterjee maintains an Underweight rating on Sensata Technologies and lowers the price target from $35 to $34.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 6:30 pm

STZ

JP Morgan analyst Andrea Teixeira maintains an Overweight rating on Constellation Brands (NYSE:STZ) but lowers the price target from $307 to $293.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 6:27 pm

NUVL

JP Morgan analyst Anupam Rama has maintained an Overweight rating on Nuvalent (NASDAQ:NUVL) and increased the price target from $100 to $125.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 6:25 pm

DTM

JP Morgan analyst Jeremy Tonet maintains a Neutral rating on DT Midstream (NYSE:DTM) but raises the price target from $78 to $83.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 6:22 pm